Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-23

Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel plus carboplatin with or without topotecan in stage IIB to IV ovarian epithelial cancer. The study also includes fallopian t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • PACLITAXEL (PACLITAXEL)
  • Topotecan (topotecan)

Snippet

Sponsor: AGO Study Group | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | Status: COMPLETED